Form 8-K - Current report:
SEC Accession No. 0000950170-25-102969
Filing Date
2025-08-05
Accepted
2025-08-05 16:00:50
Documents
60
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20250805.htm   iXBRL 8-K 56226
2 EX-99.1 dawn-ex99_1.htm EX-99.1 154018
3 EX-99.2 dawn-ex99_2.htm EX-99.2 14886
4 EX-99.3 dawn-ex99_3.htm EX-99.3 38525
5 GRAPHIC img109617361_0.jpg GRAPHIC 35151
6 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 241451
7 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 778962
8 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 233776
9 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 146595
10 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 302051
11 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 148228
12 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 271376
13 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 308661
14 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 286200
15 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 262585
16 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 258376
17 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 149134
18 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 378223
19 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 196245
20 GRAPHIC dawn-ex99_3s1.jpg GRAPHIC 224246
21 GRAPHIC dawn-ex99_3s2.jpg GRAPHIC 763177
22 GRAPHIC dawn-ex99_3s3.jpg GRAPHIC 399796
23 GRAPHIC dawn-ex99_3s4.jpg GRAPHIC 349213
24 GRAPHIC dawn-ex99_3s5.jpg GRAPHIC 352757
25 GRAPHIC dawn-ex99_3s6.jpg GRAPHIC 331252
26 GRAPHIC dawn-ex99_3s7.jpg GRAPHIC 274771
27 GRAPHIC dawn-ex99_3s8.jpg GRAPHIC 393383
28 GRAPHIC dawn-ex99_3s9.jpg GRAPHIC 355056
29 GRAPHIC dawn-ex99_3s10.jpg GRAPHIC 323072
30 GRAPHIC dawn-ex99_3s11.jpg GRAPHIC 431414
31 GRAPHIC dawn-ex99_3s12.jpg GRAPHIC 285795
32 GRAPHIC dawn-ex99_3s13.jpg GRAPHIC 308122
33 GRAPHIC dawn-ex99_3s14.jpg GRAPHIC 286960
34 GRAPHIC dawn-ex99_3s15.jpg GRAPHIC 262773
35 GRAPHIC dawn-ex99_3s16.jpg GRAPHIC 258197
36 GRAPHIC dawn-ex99_3s17.jpg GRAPHIC 409415
37 GRAPHIC dawn-ex99_3s18.jpg GRAPHIC 403899
38 GRAPHIC dawn-ex99_3s19.jpg GRAPHIC 157361
39 GRAPHIC dawn-ex99_3s20.jpg GRAPHIC 267356
40 GRAPHIC dawn-ex99_3s21.jpg GRAPHIC 302717
41 GRAPHIC dawn-ex99_3s22.jpg GRAPHIC 303847
42 GRAPHIC dawn-ex99_3s23.jpg GRAPHIC 345434
43 GRAPHIC dawn-ex99_3s24.jpg GRAPHIC 389141
44 GRAPHIC dawn-ex99_3s25.jpg GRAPHIC 397616
45 GRAPHIC dawn-ex99_3s26.jpg GRAPHIC 373572
46 GRAPHIC dawn-ex99_3s27.jpg GRAPHIC 379703
47 GRAPHIC dawn-ex99_3s28.jpg GRAPHIC 270249
48 GRAPHIC dawn-ex99_3s29.jpg GRAPHIC 358855
49 GRAPHIC dawn-ex99_3s30.jpg GRAPHIC 350996
50 GRAPHIC dawn-ex99_3s31.jpg GRAPHIC 337367
51 GRAPHIC dawn-ex99_3s32.jpg GRAPHIC 304649
  Complete submission text file 0000950170-25-102969.txt   20987145

Data Files

Seq Description Document Type Size
52 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dawn-20250805.xsd EX-101.SCH 23893
62 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20250805_htm.xml XML 4552
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 251184714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)